MENU
PHAT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Phathom Pharmaceuticals (PHAT) Ownership - Who owns Phathom Pharmaceuticals?
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
452
Web
https://www.phathompharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
279.24M
P/E Ratio
N/A
Total Cash
297.26M
Projected Growth
N/A
Total Debt
201.91M
Revenue
55.25M
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash/Share
4.27
Total Debt/Equity
N/A
Revenue/Share
0.87 USD as % of share price
Fundamentals
PHAT
Capitalization
279M
P/E Ratio
N/A
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash
297M
Total Cash/Share
4.27
Total Debt
202M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.87%
Revenue
55.3M
ROE
N/A
Book Value
-253.58M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-5.29
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
4.20
Current Revenue Per Employee
69470.73
Dividends Per Share - Security
N/A
EBITDA
-261.52M
Float
N/A
Float - Current
N/A
Gross Income Margin
87.14
Revenue To Assets
-84.41
Shares Held By Institutions
597M
Shares Outstanding - Current
69.6M
Total Liabilities
632M
Total Volume MTD
N/A
Value
-1
Gain YTD
-50.616
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
452
Web
https://www.phathompharma.com